SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 21, 2004
GUILFORD PHARMACEUTICALS INC.
(Exact name of registrant as specified in its charter)
| | | | | |
| Delaware | | 0-23736 | | 52-1841960 |
|
| (State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer Identification Number) |
| | | | | |
| 6611 Tributary Street | | | | |
| Baltimore, Maryland | | | | 21224 |
|
| (Address of principal executive offices) | | | | (Zip Code) |
Registrant’s telephone number, including area code: (410) 631-6300
(Former name or former address, if changed since last report)
INFORMATION TO BE INCLUDED IN THE REPORT
Item 5. Other Events
On June 21, 2004, Craig R. Smith made a presentation regarding the June 17, 2004 transaction between Guilford Pharmaceuticals Inc. and Symphony Neuro Development Company (“SNDC”). A copy of that presentation is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 7. Financial Statements,Pro FormaFinancial Information and Exhibits
| | 99.1 | | Presentation by Craig R. Smith M.D. regarding SNDC transaction made June 21, 2004. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | Guilford Pharmaceuticals Inc. |
| | | | | |
| Date: June 21, 2004 | | By: | | /s/ Asher M. Rubin |
| | | |
|
| | | | Asher M. Rubin
Vice President, General Counsel and Secretary |
4
INDEX TO EXHIBITS
| | | |
| Exhibit | | |
Number
| | Exhibit Description
|
| 99.1 | | Presentation by Craig R. Smith M.D. regarding SNDC transaction made June 21, 2004. |
